The Bu$iness Of Covid: Pfizer CEO Lets Out What The End Game Is

Written By BlabberBuzz | Monday, 24 January 2022 09:45 PM
3
Views 17K

On Saturday, Pfizer Inc. Chief Executive Albert Bourla announced that an annual COVID-19 vaccine would be preferable to more frequent booster shots in combating the Coronavirus pandemic.

Pfizer/BioNtech's COVID-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant yet less effective in stopping transmission.

With cases soaring, some nations have expanded COVID-19 vaccine booster programs or shortened the gap between shots as governments scramble to shore up protection.

In an interview with Israel's N12 News, Bourla was questioned whether he sees booster shots being administered every four to five months regularly.

 TECH GIANTS JOIN FORCES WITH DHS IN HERCULEAN BATTLE AGAINST CHILD EXPLOITATIONbell_image

"This will not be a good scenario. What I'm hoping (is) that we will have a vaccine that you will have to do once a year," Bourla explained.

"Once a year - it is easier to convince people to do it. It is easier for people to remember."

 HORRIFIC FOOTAGE EMERGES: FRANTIC RESCUE EFFORTS AFTER RUSSIAN MISSILES HIT UKRAINIAN CITY (WATCH)bell_image

"So from a public health perspective, it is an ideal situation. We are looking to see if we can create a vaccine that covers Omicron and doesn't forget the other variants and that could be a solution," Bourla stated.

 HIGH-STAKES SUMMIT: G7 MULLS SANCTIONS ON IRAN, WHAT SHOULD WE EXPECT?bell_image

Bourla has explained that Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron and mass produce it as soon as March.

 WATCH: NEWT GINGRICH'S APPROACH TO "DEATH TO AMERICA" CHANTSbell_image

Mentioning three studies, the U.S. Centers for Disease Control and Prevention (CDC) announced on Friday that a third dose of an mRNA vaccine is key to combating Omicron, providing 90% protection against hospitalization.

On Monday, a preliminary study published by Israel's Sheba Medical Center discovered that a fourth shot increases antibodies to even higher levels than the third but was likely not enough to fend off Omicron. Nonetheless, Sheba said that a second booster was still advised for risk groups.

 WATCH: THIS IS HAPPENING HERE IN PLAIN SIGHTbell_image

Meanwhile, White House chief medical advisor Dr. Anthony Fauci on Wednesday announced that he wishes the Food and Drug Administration approves Pfizer and BioNTech's vaccine for children under 5 years old in the next month.

 UNTHINKABLE IMPACT: ISS DEBRIS STRIKES FLORIDA RESIDENCE, NASA LAUNCHES INVESTIGATIONbell_image

"My hope is that it's going to be within the next month or so and not much later than that, but I can't guarantee that," Fauci announced throughout an interview with Blue Star Families, a nonprofit group that supports military families. "I can't outguess the FDA. I'm going to have to leave that to them."

 WATCH: HERE'S ANOTHER SURPRISING VOTE GOING TRUMP'S WAYbell_image

Fauci stated younger children will probably need three doses because two shots did not induce an adequate immune response in 2- to 4-year-olds in Pfizer's clinical trials.

“I did not at all mean to imply that the authorization would come within a month,” Fauci said in an emailed statement. “I meant that we do not know ... I am not involved in that decision.”

X